Skip to main navigation
Molecular Partners

> Top Menu

  • Partnering
  • Careers
  • Contact Us

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • Email Alerts
      • Contact IR

> Top Menu

  • Partnering
  • Careers
  • Contact Us

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • « Back
    • Overview
    • News & Events
      • « Back
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • « Back
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • « Back
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • « Back
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • « Back
      • Email Alerts
      • Contact IR

Investors

Investors

SHARE PRICE

> View All Stock

  • Detailed Share Information
Latest News
Molecular Partners Initiates Clinical Study of Trispecific Candidate MP0533 for the Treatment of Acute Myeloid Leukemia
Molecular Partners Provides Updates at 41st Annual JPM Healthcare Conference
Molecular Partners to Present at 41st Annual JP Morgan Healthcare Conference and Swiss Investor Conferences

> View All News

  • All News
Upcoming Events
March 9, 2023
Full-year results 2022
April 4, 2023
Annual General Meeting

> View All Events

  • All Events
Latest Presentation
January 12, 2023
J.P. Morgan Healthcare Conference Presentation
December 11, 2022
ASH Meeting: Key Opinion Leader Presentation
November 15, 2022
MP Corporate Presentation

> View All Presentations

  • All Presentations
Latest Financial Documents
October 27, 2022
Q3 2022 Financial Statement
August 25, 2022
Half Year Report 2022
May 12, 2022
Q1 2022 Financial Statement

> View All Reports

  • All Annual Report
Seth Lewis

Seth Lewis,
SVP Investor Relations,
Communications and Strategy

Contact Seth

STAY INFORMED

Subscribe to email alerts of your choosing

SUBSCRIBE

Institutional investors:

  REQUEST 1-1 / CALL

powered by schedulR

> Footer Menu

  • Cookie Notice
  • Privacy & Disclaimer
  • Contact Us

> Footer Social

© 2023 Molecular Partners.